Aims: Glucosamine has been safely used to relieve osteoarthritis in humans, but the precise 2 mechanism underlying its efficacy is still unclear. In this study, we investigated the direct 3 effects of glucosamine and related compounds on mast cell mediated inflammation using 4 cultured mast cells and an animal model. 5
Minneapolis, MN) was used as the secondary antibody at 1:500 dilutions for 1 h. Detection 8 was performed using Chemi-Lumi One L (Nacalai) and image-analyzer LAS-3000 9 (FUJIFILM, Tokyo, Japan). 10 
11

Quantification of TNF-α and IL-6 mRNAs by real-time RT-PCR 12
IgE-sensitized cells were treated with the indicated concentration of each glucosamine-13 related compound for 4 h as described above. After washing twice, cells were stimulated 14 with 1 µg/mL DNP-BSA for 30 min at 37℃. Cells were washed sufficiently and total RNAs 15 were extracted using the Sepasol reagent (Nacalai Tesque, Inc. Kyoto, Japan) according to the 16 manufacturer's instructions. RNAs were treated with RNase-free DNase (Invitrogen,  17 Carlsbad, CA, USA) to remove contaminating genomic DNA. After inactivating DNase by 18 heating at 65℃ for 10 min, each RNA was transcribed to cDNA using SuperScript RNaseⅡ 19 reverse transcriptase (Invitrogen, Carlsbad, CA, USA) with random hexamers at 25℃ for 10 20 min and then at 42℃ for 50 min. The reactions were stopped by incubation at 70℃ for 15 21 min and then 6 µL of each mixture, 10 µL iQ SYBR Green supermix (Bio-Rad Laboratories, 22
Hercules, CA, USA) and 2 µL TNF-α, IL-6 or GAPDH gene-specific primers (forward and 23 reverse) were mixed in a final volume of 20 µL. Primers used for the quantification of each 24 gene are listed in Table 1 . Primer pairs were selected to yield gene-specific single amplicons 25 based on the analyses by melting curves and by agarose gel electrophoresis. Real-time 1 quantitative PCR was performed using a DNA Engine Opticon system (Bio-Rad 2 Laboratories). The thermal cycler parameters were as follows: 3 min at 95℃ for one cycle, 3 followed by amplification for 40 cycles with melting for 15 seconds at 95℃ and with 4 annealing and extension for 30 seconds at 60℃. Values were normalized using GAPDH as 5 an endogenous internal standard. 6 7
Measurement of DNFB-induced mouse ear swelling 8
Six-week-old female BALB/c mice were purchased from Japan SLC Inc. (Shizuoka, 9 Japan). The animals were housed at 25℃ with a 12-hour light/dark cycle and were allowed 10 free access to commercial chow (Oriental Yeast Co., LTD., Tokyo, Japan) and tap water. 
Effect of glucosamine and related compounds on the antigen-induced degranulation of RBL-10
2H3 cells 11
As an indicator of the degranulation of RBL-2H3 cells, the release of β-hexosaminidase 12 from the cells was measured. Pre-treatment with 1 mg/mL GlcN-HCl for 4 h significantly 13 reduced the release of β-hexosaminidase from sensitized RBL-2H3 cells stimulated with 1 14 µg/mL DNP-BSA for 30 min (Fig. 1A) . The release of β-hexosaminidase from cells treated 15 with 1 mg/mL GlcN-HCl for 4h was inhibited by approximately 50% compared to cells 16 treated with antigen alone. Treatment with GlcN-HCl for 24h significantly inhibited the 17 release of β-hexosaminidase at more than 0.01 mg/mL (Fig.1B) . In contrast, GlcNAc, a 18 chitin oligomer or a chitosan oligomer had no effect on the antigen-induced degranulation of 19 mast cells (Fig. 1A and B) . GlcN-HCl, GlcNAc, chitin oligomer and chitosan oligomer had 20 no direct effect on the enzyme activity of β-hexosaminidase (data not shown). 21 
22
Effect of glucosamine and related compounds on the expression of proinflammatory cytokines 23
We examined whether glucosamine and related compounds could modulate the 24 expression of proinflammatory cytokines (TNF-α and IL-6) induced by antigen in RBL-2H3 25 cells because those cytokines from mast cells are involved in late-phase allergy. Both GlcN-1
HCl and GlcNAc significantly suppressed the antigen-induced expression of TNF-α and IL-6 2 mRNAs more than 60% compared with the control treated with antigen alone, while the 3 chitin oligomer and the chitosan oligomer had no significant effect ( Fig. 2A and B) . (Fig. 3A) . GlcNAc, chitin 14 oligomer and chitosan oligomer had no effect on the intracellular calcium mobilization. We 15 examined the effect of GlcN-HCl and GlcNAc on the tyrosine phosphorylation of Lyn which 16 is critical for degranulation. The level of phosphorylated Lyn was increased 2-fold by 17 stimulation with DNP-BSA for 5 min. In GlcN-HCl-treated cells, the DNP-BSA-induced 18 tyrosine phosphorylation of Lyn was significantly lower than in control cells (Fig. 3B) . On 19 the other hand, the activation of ERK1/2, which leads to the up-regulation of cytokines gene 20 expression, in both GlcN-HCl and GlcNAc treated cells was significantly reduced as 21 compared with that of the control cells (Fig.3C) . 22 
23
Effect of glucosamine-HCl and N-acetylglucosamine on DNFB-induced ear swelling in 24
BALB/c mice 25
To investigate anti-inflammatory activity in vivo, the effect of oral administration of 1 GlcN-HCl or GlcNAc on DNFB-induced mouse ear swelling was evaluated. DNFB-induced 2 ear swelling is a model for contact hypersensitivity and is caused by cytokines and infiltrating 3 neutrophils. We examined the effects of dietary GlcN-HCl and GlcNAc on DNFB-induced 4 immediate (6 h) and delayed (24 h) hypersensitivity. Oral administration of GlcN-HCl or 5
GlcNAc for 6 days (0.1 and 1 mg/mouse/day) significantly inhibited DNFB-induced ear 6 swelling in mice at both 6 h and 24 h after the DNFB challenge ( Fig. 4A and B) . 7
Swelling of hypodermal tissue and the infiltration of inflammatory cell were observed 8 in the ear section by histochemical analysis of hematoxylin-eosin staining. In the ear of the 9 mice administrated GlcN-HCl or GlcNAc, the pathological changes induced by DNFB 10 treatment were mitigated (Fig.5A) . The content of TNF-α in the ear of the mice 11 administrated of GlcN-HCl and GlcNAc tended to be reduced as compared with control mice. 12
Oral administration of GlcN-HCl and GlcNAc significantly reduced the concentration of 13 histamine in both ear and plasma of DNFB-treated mice ( Fig.5C and D) . 
